… crystal structure of the SARS-CoV-2 M pro , studies to discover M pro inhibitors using both
virtual … the main inhibitors selected from numerous recent studies of the SARS-CoV-2 M pro . …

… (M pro ) enzyme of SARS-CoV-2. Since, the M pro enzyme … drug target to control SARS-CoV-2
infection. By using structure… have identified five potential inhibitors of SARS-CoV-2 M pro . …

… We also found that Glu166 forms H-bonds to all of the inhibitors. Replacing … SARS-CoV-2
Mpro. Our results could contribute to the development of potential drugs inhibiting SARS-CoV-2…

… The two drugs were found to be outstanding main protease inhibitors that can also halt
SARS-CoV-2 infection. The crystal structure of the complex showed that the aldehyde group of …

… -5 could be developed as potential inhibitors of SARS-CoV-2. Moreover, we suggest that …
the S1 subsite could potentially increase the binding of molecules to the SARS-CoV-2 Mpro. …

… Taking this into consideration, we performed in silico evaluation of a set of approved drugs
as potential inhibitors of Mpro from SARS-CoV-2; our findings show that several molecules …

… This study sheds light on HIV protease drugs as prospective SARS-CoV-2 M pro inhibitors.
… suggested HIV protease drugs and remdesivir as promising SARS-CoV-2 M pro inhibitors. …

… has been made and their potential inhibitory effect against SARS–CoV-2 Mpro by
molecular … between flavonoids with sugar moieties and the main protease of the SARS-CoV-2virus. …

… binding to SARS-CoV-2 Mpro and draw a comparison to inhibitors of HIV protease that were
… resistance mutations, emphasizing potential pitfalls in the design of inhibitors that may be of …

… SARS-CoV-2 papain-like protease is considered as an important potential target for anti-SARS-CoV-2 …
to identify the possible inhibitors of the SARS-CoV-2 papain-like protease, by …